Medtech acceleration
We are serial entrepreneurs using a unique model to discover and nurture ground-breaking ideas for therapeutic medical devices.
We create and build companies to turn the best of these ideas into tools that practitioners can use to save and improve patients’ lives.
Close | Fund | AMT |
---|---|---|
2008 | MD Start I | €8.2 million |
2015 | MD Start II | €10.3 million |
2019 | Sofinnova MD Start III | €63 million |
Close: 2008
Fund: MD Start I
AMT: €8.2 million
Close: 2015
Fund: MD Start II
AMT: €10.3 million
Close: 2019
Fund: Sofinnova MD Start III
AMT: €63 million
“We’re not trying to find ways to use new technologies in medicine. We start from the clinical need. From there, we try to find technologies that will help us develop products that are going to solve that need.”
"We're not up there in the balcony giving the thumbs up or thumbs down as entrepreneurs make their pitches. We build the story; we bring in the necessary assets; we create the company, often from scratch."
Companies
MD Start
Advanced Perfusion Diagnostics
MD Start
BrightHeart
Capital & MD Start
CorWave
MD Start
Endoron Medical
MD Start
Gradient Denervation Technologies
MD Start
HEPTA Medical
MD Start
Julier Medical
MD Start & Crossover
LimFlow
Capital & MD Start
May Health
Capital & MD Start
Moon Surgical
MD Start
preCARDIA
Capital & MD Start
SafeHeal
0 results
Related News
Moon Surgical announces CE Mark for its commercial Maestro System
FDA approves Limflow System in patients with chronic limb-threatening ischemia and no suitable endovascular or surgical revascularization options
Moon Surgical's first-in-human trials feature in major surgical publication
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
Cécile Dupont, Sofinnova MD Start Partner, selected as In Vivo Rising Leader